The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence ...

As Appalachian Power continues to look into bringing a small modular reactor (SMR) to the area, ABC13 spoke with the group ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the closing of the sale of its Rare Pediatric Disease Priority ...

The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence application (sBLA) for Imfinzi (durvalumab), a human monoclonal antibody ...

An emergency order — when a restaurant is closed by the inspector — is based on an immediate threat to the public. Here, the ...

Ministers have been told to stop spending that does not contribute to the government's priorities, as Chancellor Rachel ...

Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate. The price of PRVs, which can be used to shorten ...

Chimerix plans to submit an NDA for dordaviprone to treat H3 K27M-mutant glioma, with potential U.S. FDA approval targeted ...

Investors will increasingly prioritize founders and teams who can lead with vision, scale effectively, and build resilient, ...

Federal funding to develop therapies for rare diseases could soon run out. Congress will need to reauthorize a program before it expires on December 20.

Spending that does not contribute to the government's priorities should be stopped, the Treasury will tell ministers as ...